VeraSci is a company that specializes in endpoints and clinical outcome assessments, eclinical software, HEOR consulting as well as language and translation services. Its eCOA platform Pathway is designed to promote clinical trials and studies in a range of therapeutic indications. The company focuses on dementia, multiple sclerosis, schizophrenia, Parkinson’s disease, oncology, etc.